Global and China Gelatin-Based Plasma Expander Market Insights, Forecast to 2027

Plasma compatibilizer, also known as plasma compatibilizer, plasma substitute, it is a kind of colloidal solution with molecular weight close to the plasma protein, the effect of replacing and expanding the plasma capacity depends on its colloid osmotic pressure after input into the blood vessel.The global market for gelatin polypeptide plasma volume enhancers is highly concentrated. Before 2017, the output share of the nine major enterprises reached 93.72%, and the market scale was 94.71%.The top five enterprises in the market of gelatin polypeptide plasma compatibilizer are Braun medical, Abbott, Wuhan Hualong, Zhejiang Kangle and BBCA Group. Among them, Braun medical is firmly in the top spot, accounting for 46% of production in 2018.
Global Gelatin-Based Plasma Expander key players include Braun, Abbott, Wuhan Hualong Biological Pharmaceutical Co.,Ltd., etc. Global top three manufacturers hold a share over 80%.
China is the largest market, with a share over 30%, followed by Europe, and North America, both have a share over 50 percent.
In terms of product, Content of 4.0% is the largest segment, with a share over 45%. And in terms of application, the largest application is Preoperative Prevention, followed by Cardiopulmonary Bypass and Dialysis.

Market Analysis and Insights: Global and China Gelatin-Based Plasma Expander Market
This report focuses on global and China Gelatin-Based Plasma Expander market.
In 2020, the global Gelatin-Based Plasma Expander market size was US$ 98.8 million and it is expected to reach US$ 224 million by the end of 2027, with a CAGR of 12.4% during 2021-2027. In China the Gelatin-Based Plasma Expander market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Gelatin-Based Plasma Expander Scope and Market Size
Gelatin-Based Plasma Expander market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gelatin-Based Plasma Expander market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Gelatin-Based Plasma Expander market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Content of 4.0%
Content of 3.5%
Content of 3.2%

Segment by Application
Preoperative Prevention
Cardiopulmonary Bypass and Dialysis

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Braun
Abbott
Wuhan Hualong Biological Pharmaceutical Co.,Ltd.
Zhejiang Kangle Pharmaceutical Co.,Ltd.
China BBCA Group Corporation
Harbin Sanctity Biological Pharmaceutical
Fuzhou Neptunus Futao Pharmaceuticals Co.,Ltd.
Dikang
WUHAN DOCAN PHARMACEUTICAL CO.LTD